Production of endothelium-dependent vascular relaxing factors, such as nitric oxide (NO) and prostaglandin I 2 (PGI 2 ), and endothelium-derived hyperpolarizing factor (EDHF), is regulated in part by changes in intracellular Ca 2+ concentration ([Ca 2+ ] i ) in vascular endothelial cells (ECs). Cytochrome P450 (CYP), shown to mediate endothelium-dependent hyperpolarization via epoxyeicosatrienoic acids, is one of the candidates for EDHF. In this study we tested the hypotheses that CYP might be involved in EC Ca 2+ signaling and that CYP activity might be linked with production of vasodilating factors other than EDHF. To this end, structurally different CYP inhibitors including SKF 525A, econazole and miconazole were tested on primary cultured porcine aortic endothelial cells. Intracellular Ca 2+ concentration was measured using the fluorescent Ca 2+ indicator fura-2/AM. Bradykinin (BK, 10 nM) and thapsigargin (TG, 1 µM) provoked large biphasic increases in [Ca 2+ ] i , which consist of Ca 2+ release from intracellular stores and transplasmalemmal Ca 2+ entry. SKF 525A dose-dependently (30-100 µM) inhibited BKand TG-stimulated Ca 2+ entry, but not intracellular Ca 2+ store release. Econazole (10 µM) and miconazole (10 µM) had the same effect as SKF 525A on the Ca 2+ entry. SKF 525A also dose-dependently inhibited BK-stimulated production of NO and PGI 2 , assessed by measuring cGMP and 6-keto-PGF 1α concentration. These data suggest that, in addition to its regulation of EDHF production, CYP also contributes to the regulation of other endothelium-dependent vasorelaxing factors by modifying EC Ca 2+ signaling. (Mol Cell Biochem 248: 129-134, 2003) 
Introduction

Important functions of vascular endothelial cells (ECs) depend to various extents on changes in cytosolic Ca
2+ concentration ([Ca 2+ ] i ). In particular, store-operated Ca 2+ entry (SOCE) triggered by intracellular Ca 2+ store depletion is known to regulate many endothelial functions. For example, an increase in EC [Ca 2+ ] i activates endothelial nitric oxide synthase, increasing nitric oxide (NO) production [1] [2] [3] [4] . NO released from ECs induces relaxation of underlying smooth muscle cells (SMCs) by increasing cyclic GMP levels [5, 6] . Prostacyclin (PGI 2 ) production is also stimulated by increases in [Ca 2+ ] i through the activation of phospholipase A 2 [7] [8] [9] [10] . In addition, production of endothelium-derived hyperpolarizing factor (EDHF), an endothelium-derived vasodilating factor shown to hyperpolarize and thus relax SMCs by opening K + channels, can also be stimulated by increases in EC [Ca 2+ ] i [11] . Recently it has been suggested that EDHF-mediated hyperpolarization and relaxation could be modulated by cyto-chrome P450 (CYP) isoforms expressed in the cardiovascular system. CYP inhibitors and transfection of coronary arteries with CYP 2C8/34 antisense oligonucleotides have been demonstrated to attenuate EDHF-mediated vascular responses [12, 13] . The activation of CYP epoxygenase in ECs is now considered an essential step in NO-and PGI 2 -independent vasodilatation of several vascular beds, in which CYP mediates hyperpolarization and relaxation of SMCs by enhancing the formation of 11,12-epoxyeicosatrienoic acid (EET) [13] .
However, it has not been fully elucidated whether CYP directly regulates [Ca 2+ ] i and then secondarily modifies EDHF production. If it is the case, CYP may also regulate the production of endothelium-derived relaxing factors other than EDHF by the regulation of [Ca 2+ ] i . This study was designed to assess the role of CYP in agonist-stimulated Ca 2+ signaling as well as production of NO and PGI 2 in ECs.
Materials and methods
Cell culture
Porcine aortic ECs were isolated, as previously described [14] , by gently scraping the intima of the descending part of porcine aortas. After centrifugation at 250 × g for 10 min in M199 solution (Boehringer, Mannheim, Germany), the fraction of ECs was collected from this suspension, resuspended in M199 solution with Earle's salts, supplemented with 100 IU/ml penicillin G, 100 µg/ml streptomycin, and 20% newborn calf serum (NCS), then seeded onto polybiphenyl dishes fixed on 10 × 10-mm glass cover slips, and cultured in an incubator at 37°C under 5% CO 2 for 2 days. The medium was renewed everyday. ] i analyzer (Argus 50, Hamamatsu Photonics) using an ultra-high sensitivity television camera (CCD). The fluorescence ratio was obtained after background subtraction by dividing, pixel by pixel, the 340 nm image by the 380 nm image. Bradykinin (BK), thapsigargin (TG), SKF 525A, econazole and miconazole had no effect on fura-2 fluorescence itself, or on autofluorescence of unloaded cells at concentrations used in this study.
Measurement of [
Measurement of cGMP production
Endothelial cell NO production was quantified by a reporter cell assay of cGMP production [15] . ECs (10 6 cells/well) were plated in 96-well culture dishes and incubated with M199 medium for two days at 37°C under 5% CO 2 with saturated humidity to reach confluence. Before the experiments, the medium was removed and the cells were washed with a balanced salt solution containing 130 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl 2 , 5.5 mM glucose, and 10 mM HEPES-NaOH, buffered to pH 7.3. After a 10 min incubation at room temperature in the balanced solution containing 0, 50, or 100 µM SKF 525A, the cells were treated with 10 nM BK, and the incubation was continued for another 10 min at room temperature. Cyclic GMP levels were then determined by an enzyme-linked immunoassay according to the manufacturer's protocol (EIA kit, Amersham).
Measurement of 6-keto-PGF 1α
The amount of PGI 2 released from ECs was assessed by the concentration of its stable metabolite, 6-keto-PGF 1α . ECs were plated in 12-well culture dishes and grown to confluence in medium M 199 containing 20% newborn calf serum for 2 days at 37°C under 5% CO 2 and saturated humidity. ECs were then manipulated as described in the previous section. Levels of 6-keto-PGF 1α were then determined by an enzymelinked immunoassay according to the manufacturer's protocol (EIA kit, Assay Designs).
Statistical analysis
Unless otherwise indicated, data are means ± S.D. Statistical evaluation was performed using Student's t-test for unpaired data, or one-way ANOVA followed by post hoc tests in the Systat MGLH program, where appropriate. Differences with p < 0.05 are considered significant.
Materials
Medium 199 was purchased from Boehringer (Mannheim, FRO). Newborn calf serum and penicillin-streptomycin were from GIBCO (New York, USA). Fura-2/AM was from Dojindo (Kumamoto, Japan). Bradykinin, thapsigargin, SKF525A, econazole and miconazole were from Sigma (St. Louis, MO, USA). All other chemicals were of the best available quality, usually of analytical grade.
Results
Effects of BK and TG on endothelial cell Ca
2+ concentration
In order to increase [Ca 2+ ] i in endothelial cells, we used BK, a receptor-dependent agonist, and TG, an irreversible inhibitor of the endoplasmic reticulum Ca 2+ -ATPase. In the presence of extracellular Ca 2+ , BK (10 nM) rapidly increased fura-2 fluorescence ratio, from basal ratio of 0.8 ± 0.1 (n = 21), to maximal ratio of 4.6 ± 0.4, followed by a slow-decaying sustained phase (Fig. 1A) . The rapid increase in [Ca 2+ ] i was dependent on both intracellular and extracellular Ca 2+ , while the sustained increase was dependent mainly on the presence of extracellular Ca 2+ , because BK induced only a small and transient increase in the fluorescence ratio from 0.7 ± 0.1 to 2.8 ± 0.5 in the absence of extracellular Ca 2+ (Fig. 1A) . TG (1 µM) provoked a slightly delayed but long lasting increase in the fluorescence ratio from 0.7 ± 0.1 to 4.2 ± 0.4 (Fig. 1B) . Under Ca 2+ -free conditions with medium containing 1 mM EGTA, TG (1 µM) provoked a small transient rise fura-2 fluorescence ratios from 0.6 ± 0.1 to 1.3 ± 0.2 (Fig. 1B) .
Effects of the CYP inhibitors SKF 525A, econazole and miconazole, on BK-and TG-induced Ca 2+ responses in ECs
We examined the effects of CYP inhibitors, SKF 525A, econazole and miconazole, on BK-and TG-induced Ca 2+ entry in endothelial cells. Pretreatment of the cells with SKF 525A (100 µM) for 10 min before the application of BK or TG almost completely abrogated the Ca 2+ entry phases in both BK-and TG-treated cells, with fura-2 fluorescence ratios of 0.7 ± 0.1 , 2.9 ± 0.7 , 0.8 ± 0.1 (n = 21) at baseline, 1 and 8 min after treatment with BK, respectively ( Fig. 2A) , and 0.8 ± 0.1, 1.2 ± 0.2 , 0.9 ± 0.1 at baseline, 2 and 8 min, respectively, after treatment with TG (Fig. 2B ) in the presence of 1 mM extracellular Ca 2+ . These effects of SKF 525A on BK-and TG-induced Ca 2+ responses were tested at various doses (30-100 µM, Figs 2A and 2B) . SKF 525A showed clear dose-dependency in its inhibitory effects on the BK-and TG-induced Ca 2+ responses. To examine further the effect of SKF 525A on the Ca 2+ responses, we added SKF 525A during the sustained phase of the Ca 2+ response to BK. This rapidly caused the fura-2 ratio to fall. When SKF 525A was removed, fura-2 ratio increased again (Fig. 3) . These results indicate that the inhibitory effect of SKF 525A on BK-induced Ca 2+ entry is reversible.
To rule out a non-specific effect of SKF 525A, we examined the effects of econazole and miconazole, two structurally unrelated CYP inhibitors of SKF 525A, on BK-and TG-induced Ca 2+ entry. Econazole and miconazole inhibited BKand TG-induced Ca 2+ entry to the same extent as did SKF 525A (Table 1 ). These effects of econazole and miconazole were also dose-dependent (data not shown).
Effect of SKF 525A on BK-stimulated production of cGMP and 6-keto-PGF 1α in ECs
To test the hypothesis that CYP 450 could be involved in the regulation of endothelium-dependent vasodilatation, we examined the effects of SKF 525A at various doses (50-100 µM) on cGMP and 6-keto-PGF 1α production stimulated by BK (10 nM). BK increased EC cGMP levels from 9.6 ± 5.2 pg/10 6 cells (n = 8) to 156.2 ± 24.4 pg/10 6 cells, and 6-keto-PGF 1α levels from 23.2 ± 6.2 ng/10 6 cells (n = 8) to 
Discussion
CYP enzymes are crucial for the oxidation, peroxidation, and reduction of a diverse group of substances, including steroids, fatty acids and prostanoids [16] [17] [18] [19] . These enzymes are localized mainly in the endoplasmic reticulum membranes [16] [17] [18] [19] and have been regarded as EDHF synthase because its metabolites mimicked endothelium-derived hyperpolarization [13] .
In response to various neurohumoral stimuli, ECs release NO and PGI 2 and another vasodilating factor, EDHF, which hyperpolarizes the underlying vascular SMCs. The production of EDHF is known to depend in part on intracellular Ca 2+ concentration [11] . In this study, various CYP inhibitors were examined on EC Ca 2+ signals and production of NO and PGI 2 stimulated by BK and TG. Three structurally different CYP inhibitors, SKF 525A, econazole and miconazole, all dose-dependently inhibited BK-and TGstimulated SOCE. Although SKF 525A is one of the most specific, potent and widely used CYP inhibitors known [20, 21] , it cannot be ruled out that the inhibitory effect of SKF 525A on SOCE was due to a non-specific action of the compound. However, the fact that two structurally different CYP inhibitors, econazole and miconazole, also inhibited Ca 2+ influx strongly suggests that the effects of SKF 525A, econazole and miconazole under the conditions of our experiments are specific for CYP.
We have previously demonstrated that endothelial cell SOCE plays an important role in the maintenance of the EDHF-mediated vascular responses [11] . EDHF-mediated hyperpolarization evoked by BK and cyclopiazonic acid in porcine coronary artery had a temporal correlation with SOCE in porcine aortic ECs. Furthermore, various agents that block SOCE such as myosin light chain kinase inhibitors and non-selective cation channel blockers, were shown to inhibit SMC hyperpolarization [11, 22] . The results from the present study suggest that modulation of EC Ca 2+ signaling by CYP could play a role in CYP-mediated SMC hyperpolarization. Although the relationship between the production of EETs and EC Ca 2+ responses was not addressed in this study, there is evidence that EETs stimulate SOCE [23] and membrane hyperpolarization in response to BK and TG [13] . It is not clear whether EETs directly regulate SMC hyperpolarization or indirectly influence the hyperpolarization by modulating endothelial cell SOCE and thus production of EDHF. However, it is possible from these lines of evidence that the CYP inhibitors could prevent the formation of EETs and therefore inhibit endothelial cell SOCE. In ECs, it is generally accepted that SOCE rather than intracellular Ca 2+ store release is essential for agonist-stimulated production of NO and PGI 2 . Since CYP inhibitors attenuate agonist-stimulated Ca 2+ responses by inhibiting SOCE, the inhibition of NO and PGI 2 production by SKF 525A is likely due to the inhibition of SOCE.
The non-imidazole SKF 525A, and the imidazoles, econazole and miconazole, were used to inhibit CYP activity. It has been observed that SKF 525A inhibited acetylcholinestimulated vascular relaxation by interacting with the acetylcholine receptor [24] . In our study, however, SKF 525A probably did not exert its inhibitory effects via interaction with the acetylcholine receptor, because BK-and TG-stimulated Ca 2+ responses do not involve activation of this receptor. Together, these data suggest that CYP may regulate endothelium-dependent vascular relaxation by modulating SOCE in ECs.
In summary, our data indicate that CYP, through the control of EC Ca 2+ signaling, can serve as a potential source of EDHF and can promote production important endotheliumderived relaxing factors including NO and PGI 2 .
